📈 Price History

Ratio Health

— Excellent

— Good

— Average

— Poor

By Category

📊 Sector Averages

About

Service Corporation International provides deathcare products and services in the United States and Canada. Its funeral service and cemetery operations comprise funeral service locations, cemeteries, funeral service/cemetery combination locations, crematoria, and other businesses. The company also provides professional services related to funerals and cremations, including the use of funeral home facilities and motor vehicles, arranging and directing services, removal, preparation, embalming, cremation, memorialization, and travel protection, as well as catering services. In addition, it offers funeral merchandise, including burial caskets and related accessories, urns and other cremation receptacles, outer burial containers, flowers, online and video tributes, stationery products, casket and cremation memorialization products, and other ancillary merchandise. Further, the company’s cemeteries provide cemetery property interment rights, such as developed lots, lawn crypts, mausoleum spaces, and cremation niches; custom inventory, including private mausoleums, family estates, and exclusive cremation memorialization options; and Cemetery merchandise and services, such as memorial cemetery markers and bases, outer burial containers, flowers and floral placement, other ancillary merchandise, graveside services, merchandise installation, and interments. It offers its products and services under the Dignity Memorial, Dignity Planning, National Cremation Society, Advantage Funeral and Cremation Services, Funeraria del Angel, Making Everlasting Memories, Neptune Society, and Trident Society brand names. Service Corporation International was incorporated in 1962 and is headquartered in Houston, Texas.

Key Ratios Snapshot

📈 Growth Pattern

⚡ Latest Quarter —

See full financials →

📊 Quick Scorecard

Loading…

🔍 Concall Decoded

🎙 Management Tone Tracker Confident Specific → Stable 4 quarters analysed

Q2 2025

Confident Specific

Management used phrases like 'impressive increases', 'solid 3% revenue increase', 'healthy 3.3% growth', and 'very impressive adjusted free cash flow'. They raised cash flow guidance and gave specific numbers for key metrics. Even while noting declines (e.g., pre-need funeral sales), they consistently framed them as temporary and provided recovery timelines.

Q3 2025

Confident Specific

Management uses positive language such as 'impressive increases', '10% increase', 'feel very good about our momentum', and 'robust cash flows'. They provide specific numbers (e.g., adjusted EPS $0.87, cemetery revenue up 7%, gross profit up $18M) and detailed outlook ranges, demonstrating certainty.

Q4 2025

Confident Specific

Management uses specific numbers (e.g., '11% pre-need funeral production growth', 'cemetery gross profit +3%') and expresses conviction ('we feel great about our momentum', 'we are laser-focused'), while acknowledging transitory headwinds like insurance partner transition and volume softness.

Q1 2026 latest

Confident Specific

Management repeatedly framed the quarter as showing 'strong underlying performance' and 'resilience of our business model' despite a 6.6% decline in funeral case volumes, citing 10% cemetery pre-need sales growth, 3.5% improvement in average revenue per funeral service, and reaffirmed full-year EPS guidance of $4.05–$4.35.

Guidance Reliability Pending · <3Q data

Investor Lens

The investment thesis remains intact but is now more reliant on H2 funeral volume recovery to hit the upper half of the guidance range. The underlying strength in cemetery pre-need sales and price-driven funeral revenue growth confirm the pricing power and salesforce effectiveness, which partially mitigates the volume risk. The reaffirmation of all full-year guidance suggests management confidence, but the wide EPS range ($4.05–$4.35) leaves significant uncertainty. Key items to watch next quarter: (1) funeral volume trends in Q2 and whether the recovery materializes as historical patterns suggest; (2) momentum in cemetery pre-need production against tougher comps; (3) any update on trust fund returns and their impact on recognized revenue; (4) progress on the acquisition pipeline to reach the $75–$125M target.

AI-generated concall tone analysis · Updated 2026-06-08 · Not investment advice

🎙 Management Tone Confident Specific → Stable 4 quarters Full tone analysis in Intelligence →

📊 MIXED SCI Q1 2026: EPS $0.97, funeral volumes down 6.6%, cemetery sales up 10%

Revenue & Profitability

Total comparable funeral revenues fell by $17 million or nearly 3% year-over-year. Core funeral revenues declined $18 million or just over 3%. Comparable cemetery revenue increased $31 million or about 7%. Adjusted operating cash flow was $335 million, up nearly $20 million or 6% year-over-year. Full-year 2026 normalized EPS guidance is $4.05-$4.35, with adjusted operating cash flow guidance of $1.0-$1.06 billion.

Outlook

Management expects the year-over-year rate of funeral volume decline to moderate as the year progresses, projecting a 1%-3% decline for full-year 2026. They noted that based on historical patterns from the past 20 years, after Q1 volume declines of 4%-9%, full-year results improved by an average of 400 basis points relative to Q1. The company is entering a period of meaningful demographic tailwinds.

Growth Drivers

Key growth drivers include strong Pre-need cemetery sales production (up 10% in Q1), driven by large sales ($20 million increase) and core sales ($12 million increase). Average revenue per funeral service grew 3.5%. The company is expanding its community-based sales teams, increasing seminars, and focusing on lead quality. A cremation cemetery strategy piloted in 10 markets showed success and is set to roll out to 80 more markets in July 2026.

Balance Sheet & CapEx

In Q1 2026, SCI invested $108 million in capital, including $66 million in maintenance capital ($41 million on cemetery development, $20 million on funeral home/cemetery improvements, $5 million on digital strategy), $17 million in growth capital for new funeral home construction and real estate, and $24 million in business acquisitions in multiple states. The company maintains its 2026 acquisition investment target of $75-$125 million.

Margins

Funeral gross profit margin fell 300 basis points to just over 21% due to lower revenues, partially offset by modest fixed cost growth of just over 1%. Cemetery gross profit margin expanded 120 basis points to approximately 33% due to higher-margin trust income. Management expects cemetery margins to improve 60-120 basis points for the year, while funeral margins are expected to be slightly down versus the prior year.

Key Risks

Key risks include sustained funeral volume declines; Q1 volumes were down 6.6% and April volumes remain down, though improving. Other risks include higher-than-expected fixed cost inflation (e.g., cemetery maintenance costs above inflation), volatility in trust fund returns (Q1 combined trust fund return -0.7%, though April recovery to +4-5%), and potential higher interest expense from floating rate debt.

Generated by AI · Q1 2026 results · Not investment advice

✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter

🔍

🔎 See cross-company document search → ?

📞 Earnings Call Transcripts (5)

Q2 2026 Q2 2026 2026-07-30

Second quarter 2026 saw EPS rise to $0.90, driven by strong preneed cemetery and funeral sales, robust trust fund income, and disciplined cost control. Adjusted operating cash flow and free cash flow guidance were raised, with double-digit EPS growth expected in the second half.

Q1 2026 Q1 2026 2026-04-30

Q1 2026 saw adjusted EPS rise to $0.97, with strong cemetery growth offsetting funeral volume declines. Pre-need sales and average revenue per service increased, while cost controls supported margins. 2026 guidance is reaffirmed, with improvement expected in the second half.

Q4 2025 Q4 2025 2026-02-12

Q4 and full-year 2025 saw solid EPS and cash flow growth, with margin expansion in cemetery and strong pre-need sales. 2026 guidance anticipates continued EPS and cash flow growth, stable leverage, and disciplined capital allocation, though funeral volume remains a key uncertainty.

Q3 2025 Q3 2025 2025-10-30

Q3 2025 saw adjusted EPS rise over 10% year-over-year, driven by strong cemetery growth and disciplined expense management, while funeral revenues were slightly down. 2025 guidance was reaffirmed, with robust cash flow and capital returns, and long-term EPS growth of 8%-12% targeted.

Q2 2025 Q2 2025 2025-07-31

Q2 2025 saw adjusted EPS rise 11% year-over-year, driven by funeral segment growth and cost control, while cemetery gross profit declined. Cash flow guidance was raised, with strong liquidity and capital returns, and pre-need sales are expected to rebound in the second half.

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯

Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.

📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.